Daehn, Ilse S. http://orcid.org/0000-0001-9915-5376
Duffield, Jeremy S. http://orcid.org/0000-0002-3838-0630
Article History
Accepted: 28 May 2021
First Online: 14 July 2021
Competing interests
: J.S.D. is a former employee of Vertex Pharmaceuticals, which is developing VX-147 for the treatment of APOL1-mediated kidney disease, holds Vertex stock and holds patents for the invention and use of Lademirsen for the treatment of kidney diseases including Alport syndrome. I.S.D. declares no competing interests.
Free to read: This content has been made available to all.